Concepts (159)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Undocumented Immigrants | 6 | 2020 | 17 | 2.420 |
Why?
|
| Kidney Failure, Chronic | 11 | 2020 | 960 | 2.370 |
Why?
|
| Emigrants and Immigrants | 5 | 2017 | 147 | 2.060 |
Why?
|
| Renal Dialysis | 10 | 2020 | 945 | 2.030 |
Why?
|
| Health Services Accessibility | 6 | 2020 | 761 | 1.200 |
Why?
|
| Nephritis, Interstitial | 3 | 2017 | 76 | 1.110 |
Why?
|
| Patient Protection and Affordable Care Act | 3 | 2017 | 107 | 1.080 |
Why?
|
| Music | 2 | 2015 | 36 | 0.950 |
Why?
|
| Glomerular Filtration Rate | 3 | 2015 | 602 | 0.920 |
Why?
|
| Magnesium Deficiency | 1 | 2020 | 21 | 0.770 |
Why?
|
| Health Policy | 3 | 2020 | 291 | 0.770 |
Why?
|
| Magnesium | 1 | 2020 | 160 | 0.740 |
Why?
|
| Acute Kidney Injury | 4 | 2018 | 739 | 0.710 |
Why?
|
| Uremia | 1 | 2018 | 42 | 0.640 |
Why?
|
| Kidney | 3 | 2018 | 2146 | 0.620 |
Why?
|
| Hypersensitivity, Delayed | 1 | 2017 | 104 | 0.590 |
Why?
|
| Patient Advocacy | 2 | 2013 | 92 | 0.540 |
Why?
|
| Drug Hypersensitivity | 1 | 2017 | 128 | 0.540 |
Why?
|
| Emergency Service, Hospital | 5 | 2020 | 1148 | 0.530 |
Why?
|
| Mind-Body Relations, Metaphysical | 1 | 2015 | 3 | 0.520 |
Why?
|
| Insurance, Health | 1 | 2016 | 250 | 0.490 |
Why?
|
| Medically Uninsured | 1 | 2014 | 102 | 0.470 |
Why?
|
| Famous Persons | 1 | 2013 | 23 | 0.460 |
Why?
|
| Kidney Cortex Necrosis | 1 | 2013 | 4 | 0.460 |
Why?
|
| Kidney Cortex | 1 | 2013 | 35 | 0.450 |
Why?
|
| Illness Behavior | 1 | 2013 | 29 | 0.440 |
Why?
|
| Religion and Medicine | 1 | 2013 | 50 | 0.440 |
Why?
|
| Vulnerable Populations | 1 | 2014 | 167 | 0.430 |
Why?
|
| Pre-Eclampsia | 1 | 2015 | 212 | 0.430 |
Why?
|
| Ribavirin | 1 | 2013 | 178 | 0.420 |
Why?
|
| Kidney Diseases | 2 | 2018 | 691 | 0.420 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 1362 | 0.370 |
Why?
|
| Premature Birth | 1 | 2015 | 407 | 0.370 |
Why?
|
| Physician-Patient Relations | 2 | 2020 | 792 | 0.360 |
Why?
|
| Polyethylene Glycols | 1 | 2013 | 615 | 0.340 |
Why?
|
| Colonoscopy | 1 | 2013 | 518 | 0.330 |
Why?
|
| Interferon-alpha | 1 | 2013 | 889 | 0.330 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2013 | 573 | 0.310 |
Why?
|
| Desensitization, Immunologic | 1 | 2009 | 94 | 0.310 |
Why?
|
| Hepatitis C, Chronic | 1 | 2013 | 451 | 0.310 |
Why?
|
| Nephrology | 2 | 2020 | 151 | 0.300 |
Why?
|
| Patient Satisfaction | 1 | 2013 | 915 | 0.300 |
Why?
|
| Delivery of Health Care | 1 | 2014 | 860 | 0.290 |
Why?
|
| Boronic Acids | 1 | 2009 | 362 | 0.290 |
Why?
|
| United States | 10 | 2020 | 15433 | 0.290 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2015 | 787 | 0.280 |
Why?
|
| Pyrazines | 1 | 2009 | 495 | 0.270 |
Why?
|
| Antiviral Agents | 1 | 2013 | 1230 | 0.270 |
Why?
|
| Algorithms | 1 | 2015 | 3890 | 0.240 |
Why?
|
| Biopsy | 3 | 2018 | 3443 | 0.230 |
Why?
|
| Kidney Transplantation | 1 | 2009 | 755 | 0.220 |
Why?
|
| Attitude of Health Personnel | 2 | 2020 | 918 | 0.220 |
Why?
|
| Humans | 25 | 2020 | 261506 | 0.210 |
Why?
|
| Glycosuria | 1 | 2020 | 10 | 0.200 |
Why?
|
| Renal Tubular Transport, Inborn Errors | 1 | 2020 | 11 | 0.200 |
Why?
|
| Polyuria | 1 | 2020 | 13 | 0.190 |
Why?
|
| Urinalysis | 1 | 2020 | 84 | 0.190 |
Why?
|
| Blood Chemical Analysis | 1 | 2020 | 118 | 0.180 |
Why?
|
| Texas | 3 | 2016 | 6311 | 0.180 |
Why?
|
| Prevalence | 2 | 2020 | 3260 | 0.170 |
Why?
|
| Hypothyroidism | 1 | 2020 | 204 | 0.170 |
Why?
|
| Diagnosis, Differential | 2 | 2020 | 4744 | 0.160 |
Why?
|
| Physicians | 2 | 2018 | 882 | 0.150 |
Why?
|
| For-Profit Insurance Plans | 1 | 2016 | 1 | 0.150 |
Why?
|
| beta-Lactams | 1 | 2017 | 53 | 0.150 |
Why?
|
| Urea | 1 | 2018 | 290 | 0.140 |
Why?
|
| Morbidity | 1 | 2017 | 397 | 0.140 |
Why?
|
| Blood Glucose | 1 | 2020 | 1244 | 0.140 |
Why?
|
| Oligohydramnios | 1 | 2015 | 37 | 0.130 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2015 | 59 | 0.130 |
Why?
|
| Medicare | 1 | 2020 | 860 | 0.130 |
Why?
|
| Emergencies | 1 | 2016 | 202 | 0.130 |
Why?
|
| Perinatal Death | 1 | 2015 | 31 | 0.130 |
Why?
|
| Epitopes | 1 | 2017 | 685 | 0.120 |
Why?
|
| Proton Pump Inhibitors | 1 | 2017 | 249 | 0.120 |
Why?
|
| Education, Medical, Graduate | 1 | 2020 | 671 | 0.120 |
Why?
|
| Male | 10 | 2020 | 123000 | 0.120 |
Why?
|
| Insurance Coverage | 1 | 2016 | 256 | 0.120 |
Why?
|
| History, Medieval | 1 | 2013 | 30 | 0.120 |
Why?
|
| History, 16th Century | 1 | 2013 | 34 | 0.120 |
Why?
|
| History, 17th Century | 1 | 2013 | 40 | 0.120 |
Why?
|
| History, Ancient | 1 | 2013 | 68 | 0.120 |
Why?
|
| Fetal Growth Retardation | 1 | 2015 | 194 | 0.120 |
Why?
|
| History, 18th Century | 1 | 2013 | 89 | 0.120 |
Why?
|
| Female | 9 | 2020 | 141928 | 0.110 |
Why?
|
| Religion and Psychology | 1 | 2013 | 27 | 0.110 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 521 | 0.110 |
Why?
|
| Early Diagnosis | 1 | 2014 | 298 | 0.110 |
Why?
|
| History, 19th Century | 1 | 2013 | 154 | 0.110 |
Why?
|
| Steroids | 1 | 2014 | 356 | 0.110 |
Why?
|
| Observational Studies as Topic | 1 | 2013 | 140 | 0.110 |
Why?
|
| Electronic Health Records | 1 | 2020 | 929 | 0.110 |
Why?
|
| Renal Replacement Therapy | 1 | 2013 | 135 | 0.100 |
Why?
|
| Cesarean Section | 1 | 2015 | 367 | 0.100 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2018 | 595 | 0.100 |
Why?
|
| Gestational Age | 1 | 2015 | 1069 | 0.100 |
Why?
|
| Hospitals, Public | 1 | 2011 | 64 | 0.100 |
Why?
|
| Viral Load | 1 | 2013 | 493 | 0.100 |
Why?
|
| History, 20th Century | 1 | 2013 | 574 | 0.100 |
Why?
|
| Odds Ratio | 1 | 2015 | 2316 | 0.090 |
Why?
|
| Risk Factors | 3 | 2018 | 17523 | 0.090 |
Why?
|
| Depressive Disorder | 1 | 2013 | 557 | 0.080 |
Why?
|
| Chronic Disease | 1 | 2014 | 1819 | 0.080 |
Why?
|
| Severity of Illness Index | 2 | 2018 | 4320 | 0.080 |
Why?
|
| HLA-A Antigens | 1 | 2009 | 102 | 0.080 |
Why?
|
| Aged | 5 | 2020 | 70117 | 0.080 |
Why?
|
| Mycophenolic Acid | 1 | 2009 | 148 | 0.080 |
Why?
|
| Remission Induction | 1 | 2014 | 3569 | 0.080 |
Why?
|
| Logistic Models | 1 | 2015 | 3441 | 0.080 |
Why?
|
| Sulfonamides | 1 | 2017 | 1823 | 0.080 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 4298 | 0.080 |
Why?
|
| Sex Factors | 1 | 2013 | 2139 | 0.080 |
Why?
|
| Recombinant Proteins | 1 | 2013 | 2927 | 0.070 |
Why?
|
| Retrospective Studies | 5 | 2018 | 37905 | 0.070 |
Why?
|
| Histocompatibility Testing | 1 | 2009 | 447 | 0.070 |
Why?
|
| Double-Blind Method | 1 | 2013 | 2588 | 0.070 |
Why?
|
| Bortezomib | 1 | 2009 | 543 | 0.070 |
Why?
|
| Waiting Lists | 1 | 2009 | 263 | 0.070 |
Why?
|
| Comorbidity | 1 | 2013 | 2352 | 0.070 |
Why?
|
| Quality of Health Care | 1 | 2011 | 621 | 0.070 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2009 | 864 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 4892 | 0.070 |
Why?
|
| Surveys and Questionnaires | 2 | 2020 | 5687 | 0.070 |
Why?
|
| Length of Stay | 1 | 2012 | 1900 | 0.060 |
Why?
|
| Autoantibodies | 1 | 2009 | 576 | 0.060 |
Why?
|
| Incidence | 1 | 2015 | 5673 | 0.060 |
Why?
|
| Immunologic Factors | 1 | 2009 | 649 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2018 | 32848 | 0.060 |
Why?
|
| Middle Aged | 6 | 2018 | 86204 | 0.060 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2009 | 1033 | 0.060 |
Why?
|
| Rituximab | 1 | 2009 | 1528 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2018 | 5542 | 0.060 |
Why?
|
| Adult | 4 | 2015 | 77950 | 0.060 |
Why?
|
| Disease Progression | 1 | 2014 | 6682 | 0.060 |
Why?
|
| B-Lymphocytes | 1 | 2009 | 1294 | 0.060 |
Why?
|
| Immunosuppressive Agents | 1 | 2009 | 1375 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2015 | 6869 | 0.050 |
Why?
|
| Infant, Newborn | 1 | 2015 | 8223 | 0.050 |
Why?
|
| Pregnancy | 1 | 2015 | 7573 | 0.050 |
Why?
|
| Cohort Studies | 1 | 2013 | 9244 | 0.050 |
Why?
|
| Workload | 1 | 2020 | 198 | 0.040 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2020 | 220 | 0.040 |
Why?
|
| Safety-net Providers | 1 | 2018 | 53 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2013 | 12873 | 0.040 |
Why?
|
| Faculty, Medical | 1 | 2020 | 289 | 0.040 |
Why?
|
| Interviews as Topic | 1 | 2018 | 497 | 0.040 |
Why?
|
| Young Adult | 1 | 2015 | 21445 | 0.040 |
Why?
|
| Fellowships and Scholarships | 1 | 2020 | 390 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2009 | 4367 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2018 | 556 | 0.030 |
Why?
|
| Time Factors | 2 | 2020 | 12926 | 0.030 |
Why?
|
| Survival Rate | 2 | 2018 | 12221 | 0.030 |
Why?
|
| Adolescent | 1 | 2015 | 31252 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2013 | 15862 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2018 | 1270 | 0.020 |
Why?
|
| Neoplasms | 1 | 2013 | 15193 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 14889 | 0.010 |
Why?
|
| Prognosis | 1 | 2013 | 21713 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 29902 | 0.010 |
Why?
|